SCHEMBL22683012

SCHEMBL22683012

CCn1c(-c2cccc(C(F)(F)F)c2)cc2cc(N)ccc21.CCn1c(-c2cccc(C(F)(F)F)c2)cc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.44
ABCG2 Q9UNQ0 10/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 1/20 0.40
CYP1A2 P05177 1/20 0.40
MAPK14 Q16539 1/20 0.39
SCN2A Q99250 1/20 0.39
CFTR P13569 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
KIF11 P52732 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17199253 0.94 CYP19A1 (0.49) CYP19A1ABCG2MEN1KMT2ALMNA
SCHEMBL17199125 0.89 GRIK1 (0.45) ABCG2MEN1KMT2AMAPTCYP1A2
SCHEMBL17199149 0.82 CYP19A1 (0.49) CYP19A1MEN1KMT2ALMNAMAPT
SCHEMBL2425532 0.80 CYP19A1 (0.52) CYP19A1ABCG2MEN1KMT2ALMNA
SCHEMBL2421702 0.78 CYP19A1 (0.69) CYP19A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL17199186 0.78 CYP19A1 (0.52) CYP19A1MEN1KMT2ALMNAMAPT
SCHEMBL18470554 0.76 GRIK1 (0.46) KMT2AMAPK14
SCHEMBL17199129 0.76 GRIK1 (0.45) MEN1KMT2AMAPTKIF11
SCHEMBL18523466 0.75 CYP19A1 (0.61) CYP19A1MEN1KMT2ALMNAMAPT
SCHEMBL2419878 0.74 CYP19A1 (0.52) CYP19A1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3133068-B1 AMIDE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREFOR AND MEDICINAL APPLICATION THEREOF Shanghai hengrui pharmaceutical co ltd (CN) 2020-11-25 EP disclosed